These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25265823)

  • 1. Stability of [(N-piperidine)methylene]daunorubicin hydrochloride and [(N-pyrrolidine)methylene]daunorubicin hydrochloride in solid state.
    Medenecka B; Zalewski P; Kycler W; Piekarski M; Lemiech W; Oszczapowicz I; Jelińska A
    Acta Pol Pharm; 2014; 71(3):431-8. PubMed ID: 25265823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of [(N-morpholine)metylene]daunorubicin hydrochloride in solid state.
    Zalewski P; Jelińska A; Prusinowska P; Cielecka-Piontek J; Krause A; Oszczapowicz I
    Acta Pol Pharm; 2011; 68(5):759-63. PubMed ID: 21928722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the stability of doxorubicin and daunorubicin in solid state.
    Cielecka-Piontek J; Jelińska A; Zajac M; Sobczak M; Bartold A; Oszczapowicz I
    J Pharm Biomed Anal; 2009 Nov; 50(4):576-9. PubMed ID: 19195811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of epidoxorubicin in solid state.
    Sobczak A; Jelińska A; Leśniewska M; Firlej A; Oszczapowicz I
    J Pharm Biomed Anal; 2011 Mar; 54(4):869-72. PubMed ID: 21112717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of pH and temperature on the stability of N-[(piperidine)methylene]daunorubicin Hydrochloride and a comparison of the stability of daunorubicin and its four new amidine derivatives in aqueous solutions.
    Piekarski M; Dołhań A; Cielecka-Piontek J; Zalewski P; Kycler W; Kaczmarek A; Firlej A; Oszczapowicz I; Jelińska A
    ScientificWorldJournal; 2014; 2014():803789. PubMed ID: 24688433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of diltiazem hydrochloride in solid phase.
    Muszalska I; Siakowski M
    Acta Pol Pharm; 2003; 60(1):27-30. PubMed ID: 12848364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of degradation of imidapril hydrochloride in finished dosage formulations.
    Stanisz B; Regulska K
    Acta Pol Pharm; 2013; 70(4):737-42. PubMed ID: 23923397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of omeprazole degradation in solid state.
    Popielarz-Brzezińska M
    Acta Pol Pharm; 2011; 68(5):753-7. PubMed ID: 21928721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of cefotaxime sodium in solid state.
    Zajac M; Musiał W; Pawłowski L
    Pharmazie; 2000 Dec; 55(12):917-8. PubMed ID: 11189867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of relative humidity and temperature on stability of moexipril hydrochloride in solid phase.
    Stanisz B
    Acta Pol Pharm; 2004; 61(2):91-6. PubMed ID: 15493289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability studies of cefoselis sulfate in the solid state.
    Zalewski P; Skibiński R; Talaczyńska A; Paczkowska M; Garbacki P; Cielecka-Piontek J
    J Pharm Biomed Anal; 2015 Oct; 114():222-6. PubMed ID: 26073113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of the crystalline form of cefaclor monohydrate and its pharmaceutical preparations.
    Medenecka B; Jelińska A; Zajac M; Bałdyka M; Juszkiewicz K; Oszczapowicz I
    Acta Pol Pharm; 2009; 66(5):563-9. PubMed ID: 19894653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of humidity and hydroxypropyl cellulose, hydroxypropylmethyl cellulose, glyceryl behenate or magnesium stearate on the degradation kinetics of quinapril hydrochloride in solid phase.
    Stanisz B; Paszun S; Strzyzycka N; Ptaszyński E
    Acta Pol Pharm; 2010; 67(1):99-102. PubMed ID: 20210086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors.
    Teixeira RS; Valduga CJ; Benvenutti LA; Schreier S; Maranhão RC
    J Pharm Pharmacol; 2008 Oct; 60(10):1287-95. PubMed ID: 18812021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-base catalysis of N-[(morpholine)methylene]daunorubicin.
    Krause A; Jelińska A; Cielecka-Piontek J; Klawitter M; Zalewski P; Oszczapowicz I; Wąsowska M
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1024-8. PubMed ID: 22124459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of cefamandole nafate degradation in solid phase.
    Jelińska A; Zajac M; Gostomska J; Szczepaniak M
    Farmaco; 2003 Apr; 58(4):309-13. PubMed ID: 12727540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of aztreonam in AZACTAM.
    Zajac M; Jelińska A; Cielecka-Piontek J; Oszczapowicz I
    Farmaco; 2005; 60(6-7):599-603. PubMed ID: 15932754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability studies of cefpirome sulfate in the solid state: Identification of degradation products.
    Zalewski P; Skibiński R; Cielecka-Piontek J
    J Pharm Biomed Anal; 2014 Apr; 92():22-5. PubMed ID: 24469097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stability-indicating, ion-pairing, reversed-phase liquid chromatography method for studies of daunorubicin degradation in i.v. infusion fluids.
    Respaud R; Quenum L; Plichon C; Tournamille JF; Gyan E; Antier D; Viaud-Massuard MC
    J Pharm Biomed Anal; 2013 Sep; 83():164-70. PubMed ID: 23747490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and properties of the 14-amino derivatives of daunorubicin and carminomycin].
    Povarov LS; Isaeva NN
    Antibiotiki; 1979 Feb; 24(2):92-6. PubMed ID: 434804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.